Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07200414Not ApplicableCompleted

Strengthening HPV Vaccination and Adolescent Health Research Program in Nigeria (SHARP)

Role: collaborator

NCT06387511Not ApplicableCompleted

Increasing Measles Vaccination Coverage Through Supplementation With an SQ-LNS Incentive in Children Aged 6-23 Months

Role: collaborator

NCT06258200Not ApplicableActive Not Recruiting

The Role of Gender Transformative Interventions to Strengthen Gender Equity and Improve Immunization Outcomes

Role: collaborator

NCT06650956Not ApplicableRecruiting

Integration to Improve Adolescent Health and HPV Vaccination in Laos

Role: collaborator

NCT02727855Completed

Cholera Vaccine Investment Strategy in Bangladesh

Role: collaborator

All 5 trials loaded